These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29108961)

  • 21. Rare cancers: Challenges & issues.
    Pillai RK; Jayasree K
    Indian J Med Res; 2017 Jan; 145(1):17-27. PubMed ID: 28574010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Networking in rare cancers: What was done, what's next.
    Frezza AM; Trama A; Blay JY; Casali PG
    Eur J Surg Oncol; 2019 Jan; 45(1):16-18. PubMed ID: 29685758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The challenge of very rare tumours in childhood: the Italian TREP project.
    Ferrari A; Bisogno G; De Salvo GL; Indolfi P; Perilongo G; Cecchetto G; ;
    Eur J Cancer; 2007 Mar; 43(4):654-9. PubMed ID: 17049226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rare tumors: A comprehensive analysis of cancer.
    Bondei Irina T; Ofelia S; Todor N; Viorica Magdalena N
    J BUON; 2019; 24(5):2173-2179. PubMed ID: 31786892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic literature review of evidence-based clinical practice for rare diseases: what are the perceived and real barriers for improving the evidence and how can they be overcome?
    Rath A; Salamon V; Peixoto S; Hivert V; Laville M; Segrestin B; Neugebauer EAM; Eikermann M; Bertele V; Garattini S; Wetterslev J; Banzi R; Jakobsen JC; Djurisic S; Kubiak C; Demotes-Mainard J; Gluud C
    Trials; 2017 Nov; 18(1):556. PubMed ID: 29166947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why American women are not receiving state-of-the-art gynecologic cancer care.
    Gershenson DM
    Cancer J; 2001; 7(6):450-7. PubMed ID: 11769855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
    Parker S
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rare cancers in The Netherlands: a population-based study.
    van der Zwan JM; van Dijk BAC; Visser O; van Krieken HJHJM; Capocaccia R; Siesling S
    Eur J Cancer Prev; 2018 Jul; 27(4):384-390. PubMed ID: 25969132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rare cancers of the head and neck area in Europe.
    Van Dijk BA; Gatta G; Capocaccia R; Pierannunzio D; Strojan P; Licitra L;
    Eur J Cancer; 2012 Apr; 48(6):783-96. PubMed ID: 22051735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Challenges for clinical research on rare tumors in Europe].
    Blay JY
    Bull Acad Natl Med; 2013 Jan; 197(1):103-21; discussion 121-2. PubMed ID: 24672983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The European Paediatric Rare Tumours Network - European Registry (PARTNER) project for very rare tumors in children.
    Orbach D; Ferrari A; Schneider DT; Reguerre Y; Godzinski J; Bien E; Stachowicz-Stencel T; Surun A; Almaraz RL; Dragomir M; Jani D; Ami TB; Roganovic J; Brecht IB; Ladenstein R; Bisogno G
    Pediatr Blood Cancer; 2021 Jun; 68 Suppl 4():e29072. PubMed ID: 33913610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of care in surgery for ovarian cancer in Europe.
    Verleye L; Vergote I; van der Zee AG
    Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S108-14. PubMed ID: 20580524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National registries of rare diseases in Europe: an overview of the current situation and experiences.
    Taruscio D; Vittozzi L; Choquet R; Heimdal K; Iskrov G; Kodra Y; Landais P; Posada M; Stefanov R; Steinmueller C; Swinnen E; Van Oyen H
    Public Health Genomics; 2015; 18(1):20-5. PubMed ID: 25228300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rare tumours: a new heading in Bulletin du cancer].
    Massard C; Droz JP
    Bull Cancer; 2010 Sep; 97(9):1031-9. PubMed ID: 20813656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Centres of Expertise and European Reference Networks: key issues in the field of rare diseases. The EUCERD Recommendations.
    Taruscio D; Gentile AE; Evangelista T; Frazzica RG; Bushby K; Montserrat AM
    Blood Transfus; 2014 Apr; 12 Suppl 3(Suppl 3):s621-5. PubMed ID: 24922304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rare Diseases in Europe: from a Wide to a Local Perspective.
    Baldovino S; Moliner AM; Taruscio D; Daina E; Roccatello D
    Isr Med Assoc J; 2016 Jun; 18(6):359-63. PubMed ID: 27468531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Epidemiology and management of rare paediatric tumours within the framework of the French Society for Children Cancer].
    Réguerre Y; Lacour B; André N; Claude L; Hameury F; Lavrand F; Kalfa N; Peuchmaur M; Orbach D
    Bull Cancer; 2010 Sep; 97(9):1041-5. PubMed ID: 20813657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The importance of international collaboration for rare diseases research: a European perspective.
    Julkowska D; Austin CP; Cutillo CM; Gancberg D; Hager C; Halftermeyer J; Jonker AH; Lau LPL; Norstedt I; Rath A; Schuster R; Simelyte E; van Weely S
    Gene Ther; 2017 Sep; 24(9):562-571. PubMed ID: 28440796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival from rare cancer in adults: a population-based study.
    Gatta G; Ciccolallo L; Kunkler I; Capocaccia R; Berrino F; Coleman MP; De Angelis R; Faivre J; Lutz JM; Martinez C; Möller T; Sankila R;
    Lancet Oncol; 2006 Feb; 7(2):132-40. PubMed ID: 16455477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.